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Cerebral cavernous malformations (CCMs) are neu-
rovascular lesions caused by mutations in one of
three genes (CCM1–3). Loss of CCM3 causes the
poorest prognosis, and little is known about how it
regulates vascular integrity. The C. elegans ccm-3
gene regulates the development of biological tubes
that resemble mammalian vasculature, and in a
genome-wide reverse genetic screen, we identified
more than 500 possible CCM-3 pathway genes.
With a phenolog-like approach, we generated a hu-
man CCM signaling network and identified 29 genes
in common, of which 14 are required for excretory
canal extension and membrane integrity, similar to
ccm-3. Notably, depletion of the MO25 ortholog
mop-25.2 causes severe defects in tube integrity by
preventing CCM-3 localization to apical membranes.
Furthermore, loss of MO25 phenocopies CCM3
ablation by causing stress fiber formation in endo-
thelial cells. This work deepens our understanding
of how CCM3 regulates vascular integrity and may
help identify therapeutic targets for treating CCM3
patients.
INTRODUCTION
The nematode worm Caenorhabditis elegans contains several
biological tubes, including multicellular tubes such as the intes-
tine and germline as well as the unicellular excretory canals.
Defects in the development or maintenance of these organs
are often lethal to the organism or compromise its fitness. We
recently developed C. elegans models of the neurovascular dis-
ease cerebral cavernous malformation (CCM) and discovered
key roles for the worm CCM3 gene, ccm-3, in promoting the
extension and maintenance of excretory canals (Lant et al.,
2015) and germline development (Pal et al., 2017). The function
of CCM-3 is dependent on its protein binding partners within
the striatin interacting phosphatase and kinase (STRIPAK)
complex, and loss of ccm-3 or STRIPAK genes causes defectsCell Reports 24, 2857–
This is an open access article undin endocytic recycling and cytoskeletal organization (Lant
et al., 2015; Pal et al., 2017). However, we lack a comprehen-
sive understanding of how CCM-3/STRIPAK regulates these
biological processes. Because of its genetic tractability and
conservation of core CCM genes we took advantage of
C. elegans to interrogate the CCM gene network.
CCMaffects1 in 250 individuals and is caused byweak junc-
tions in blood capillaries, which can leak blood into the brain
parenchyma. This causes symptoms that range from mild head-
aches and seizures to hemorrhagic stroke, and it is not possible
to predict when a lesion will bleed. The only treatment presently
available for these patients is surgical resection, which can have
devastating effects depending on lesion location. CCM can arise
sporadically or, in approximately 40%of cases, by inheritance of
mutations in one of the three CCM genes (CCM1/KRIT1, CCM2/
OSM, and CCM3/PDCD10) (Fischer et al., 2013). These genes
encode three distinct scaffold proteins that form a hetero-
trimeric complex, in which loss of any one can cause activation
of the small GTPase RhoA and stimulation of Rho kinase
(ROCK) (Borikova et al., 2010). This causes actin stress fiber
formation, which compromises the integrity of cell-cell junctions.
Although CCM1 is the most commonly mutated gene, mutations
in CCM3 cause the earliest onset and most aggressive form of
this disease (Shenkar et al., 2015).
A possible reason for the enhanced aggressiveness associ-
ated with CCM3 mutations may be that it functions in multiple
complexes concurrently. Along with the hetero-trimeric CCM
complex, CCM3 is also present in the STRIPAK complex (Kean
et al., 2011). This complex contains a striatin backbone to
which CCM3 binds and provides both phosphorylation and
de-phosphorylation activity through germinal center kinase
class III (GCKIII) kinases (MST3, MST4, and MST20) and protein
phosphatase 2 (PP2A/C), respectively (Kean et al., 2011). Also
bound to striatin is the MOB kinase activator (MOB3) and the
striatin-interacting proteins (STRIP1/2), which themselves tether
a number of proteins, including the sarcolemma-associated
protein (SLMAP), IKK kinase suppressor (SIKE), and cortactin-
binding protein (CTTNBP2) (Kean et al., 2011). STRIPAK has
been implicated in a number of human diseases (Hwang and
Pallas, 2014) and uses CCM3 as a kinase adaptor (Ceccarelli
et al., 2011). CCM/GCKIII activity affects Golgi localization
(Kean et al., 2011) and cytoskeletal organization by directing2868, September 11, 2018 ª 2018 Hospital for Sick Children. 2857
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Flowchart of Genome-wide RNAi Screen
Taking advantage of the synthetic lethal interaction previously identified
between kri-1/CCM1 and ccm-3/CCM3 (Lant et al., 2015), 562 genes were
identified that exhibit negative interactions (Emb. Let., embryonic lethality,
sterility, or slow growth; Larv. Let., larval lethality; Syn. Let., synthetic lethality)
when ablated by RNAi in kri-1 mutants. In parallel, a phenolog-like approach
using GeneMANIA and STRING was used to generate a ‘‘CCM-ome’’ from
genes known to function in human CCM signaling pathways. The 29 over-
lapping genes between these two sets (‘‘tier 1 hits’’) were assessed for ccm-3
phenotypes in C. elegans, such as excretory canal truncations. See also
Figure S1.the phosphorylation of a number of substrates, such as the
actin-binding protein moesin (Zheng et al., 2010). Furthermore,
emerging evidence indicates that CCM3 is able to act indepen-
dently of the other two CCM proteins (Lant et al., 2015; Yoruk
et al., 2012; You et al., 2017; Zhou et al., 2016a).
Although there have been intense efforts to understand the
mechanisms bywhich CCM1 andCCM2 regulate vascular integ-2858 Cell Reports 24, 2857–2868, September 11, 2018rity, much less is known about the role of CCM3. Our aim in this
study was to interrogate the C. elegans ccm-3 network by first
conducting a whole-genome RNAi screen to identify a compre-
hensive set of genes that exhibit similar synthetic lethal interac-
tions with kri-1/CCM1 as ccm-3 (Figure 1). Large-scale reverse
genetics screens inC. elegans havemany advantages for under-
standing poorly characterized genes, which often provide impor-
tant insights into the biological functions of genes implicated in
human diseases (Meier et al., 2014; Silverman et al., 2009; Sin
et al., 2014). We uncovered more than 500 genes that exhibited
strong negative genetic interactions with kri-1 and function in a
range of cellular processes, including vesicle trafficking and
cytoskeletal dynamics. By using a phenolog-like approach
(McGary et al., 2010), we cross-referenced these C. elegans
genes with a network assembled from genes previously shown
to function in human CCM signaling. The resultant 29 genes
(tier 1 hits) were systematically knocked down by RNAi and eval-
uated for ccm-3-specific phenotypes, such as excretory canal
truncations. Of the 29 tier 1 genes, 14 caused strong excretory
canal truncations and membrane defects when knocked down
in wild-type animals. The most severe canal defects were
caused by ablation of mop-25.2, a homolog of mouse embryo
scaffolding protein 25 (MO25), which is involved in mediating
AMPK signaling (Boudeau et al., 2003, 2004). Our analysis re-
veals a role for MOP-25.2, independent of its canonical binding
partners, in the localization of both CCM-3 and GCK-1 to apical
membranes necessary for biological tube integrity. Finally, we
show that loss ofMO25 phenocopiesCCM3 ablation in endothe-
lial cells by causing actin stress fiber formation. The combination
of unbiased screening and bioinformatics analysis in C. elegans
affords a powerful and efficient method for understanding how
CCM proteins regulate biological tube development and may
even uncover therapeutic targets.
RESULTS
Whole-Genome Screen to Identify Genes in the ccm-3
Pathway
We previously observed that, although loss of neither kri-1 nor
ccm-3 on its own affects the survival of the worm, ablation of
ccm-3 in kri-1 mutants results in synthetic lethality (Lant et al.,
2015). We reasoned that other genes that cause similar negative
genetic interactions with kri-1 may act in the ccm-3 pathway or
cooperate with its in vivo functions. Therefore, we conducted
a full-genomeRNAi screen using the Source BioScience RNAi Li-
brary, which covers 96% of annotated genes in the C. elegans
genome, and identified 562 genes that reduced fitness of kri-1
mutants but not wild-type worms (Figure 1). These phenotypes,
which include lethality at all stages of development, slow growth,
and reduced fertility, all represent negative genetic interactions
(Figure S1). Using the GeneMANIA application in Cytoscape,
we constructed a network on the basis of these interactions to
evaluate connectivity between our screen hits and genes known
to be involved in CCM signaling (Figures S1 and S2, blue circles).
Of the 562 genes identified, 237 had annotated interactions
(genetic, physical, and/or predicted) with one another, while
the remaining 325 ‘‘orphan’’ genes had only genetic interactions
with kri-1 (Figure S1). For this study we focused on the 237 genes
Figure 2. C. elegans CCM Network Map
The network, with gene clusters showing enrich-
ments in specific signaling pathways and cellular
processes, was constructed using the GeneMANIA
app in Cytoscape and gene annotations from
Wormbase (www.wormbase.org). Genetic, phys-
ical, and predicted interactions are marked with
green, pink, and orange lines, respectively. Nega-
tive hits from the primary screen are shown to
have interaction with the CCM-related genes (blue
spheres). Hits that will later be identified as ‘‘tier 1’’
are indicated by triangular outline.
See also Tables S1 and S4 and Figure S2.with documented interactions. Using Gene Ontology (GO)
classification, these genes were found to be associated with a
number of cellular processes, with a notable enrichment in cell
localization and migration categories (including cell migration,
cell motility, localization of the cell, and inductive cell migration)
(Figure S2). Analysis of their functional roles indicate that a num-
ber fall into well-defined signaling cascades or cell process cat-
egories (Figure 2; Table S1). For example, we identified several
cytoskeletal genes (i.e., actin, tubulin, interfilament organizer,
and chaperones) and genes involved in small G protein signaling
(i.e., small GTPases, GEF, and RHO-activating proteins). This is
in line with previously described roles of CCM proteins in the
regulation of actin polymerization and cell junction stability
through Rho signaling (Borikova et al., 2010; Stockton et al.,
2010; Whitehead et al., 2009). Consistent with observations in
mammalian systems (Draheim et al., 2015; Zhou et al., 2015,
2016b) we also identified a number of MAPK signaling genes,
such as a MEKK3 kinase, MAPK phosphatases, and a KLF
transcription factor. Finally, several vesicle-trafficking proteins
(including the exocyst complex, endosome-associated GTPase,
and components of the adaptin complex) were identified,
consistent with our recent observations on CCM-3/STRIPAK
function in biological tube development (Lant et al., 2015; Pal
et al., 2017).
To refine the primary network into a set of genes that are
evolutionarily conserved, we used a ‘‘phenolog’’-like approachCell Reports(McGary et al., 2010). We reasoned that
filtering the primary screen hits to identify
nematode genes with human homologs
would enrich for genes relevant to
CCM biology. We selected 35 genes
(Table S4) previously shown to function
in human CCM signaling (Borikova et al.,
2010; Fischer et al., 2013; Glading and
Ginsberg, 2010; Storkebaum et al.,
2011; Zhang et al., 2013a) to generate a
predicted ‘‘CCM-ome.’’ This CCM-ome
gene list, generated using GeneMANIA
and STRING algorithms, was converted
to their nematode orthologs, yielding
653 genes (see STAR Methods for more
details). Comparing this list with the 562
genes identified from the unbiased RNAi
screen revealed 29 genes in common,which we refer to as ‘‘tier 1’’ hits (Figure 2, triangles, and Fig-
ure 3A; Table 1). We reasoned that genes identified in the RNAi
screen that are orthologous to human genes in the CCM-ome
would predict roles in CCM3 biology.
To investigate their in vivo functions, we used the C. elegans
excretory canal as a model. This unicellular tube extends bi-di-
rectionally along both sides of the worm and functions as a renal
system for the animal (Nelson and Riddle, 1984) (Figure 3B).
Loss of ccm-3 causes significant truncations and ‘‘cyst’’ forma-
tion in excretory canals (Lant et al., 2015). We systematically ab-
lated the 29 tier 1 genes by RNAi in wild-type animals and quan-
tified excretory canal lengths. This was compared with a list of
29 randomly selected ‘‘control set’’ genes (Table S2). We found
that the tier 1 set was significantly enriched (p = 6.9 3 1036) for
genes that caused canal truncations compared with the control
set (Figures 3C, S3A, and S3B). Using the distribution of canal
lengths under control conditions (Figure 3B), we denote ‘‘trun-
cations’’ as canals that are <80% the length of those in wild-
type animals. For a gene to cause a biologically relevant trunca-
tion when ablated, it must cause at least 5 times more canal
truncations in the population of worms compared with control
RNAi; a population of worms on control RNAi exhibits 7%
truncation (33 of 500), so for a gene to cause truncation,
R35% of animals must have truncated canals. We defined a
strong truncation to be similar to ccm-3 mutants (R80% of an-
imals with truncated canals). Analysis of individual genes within24, 2857–2868, September 11, 2018 2859
Figure 3. Effect of Tier 1 Genes on Excretory Canal Lengths
(A) Genes classified as tier 1 hits (red) form a highly interactive network with
CCM-associated genes (blue). Tier 1 hits were secondarily analyzed for the
ccm-3-mutant phenotype, excretory canal truncation.
(B) Worm canals were measured as a ratio of canal length to body length.
(C) Quantitation of canal truncations shows that tier 1 hits produced
significantly more truncated canals than wild-type canals (n = 1,450; * and
**p < 0.05), and a randomly generated ‘‘control set’’ of genes. Analysis of
individual tier 1 hits (Table 1) also indicated genes that caused truncations
(triangle) and strong truncations (diamond) when ablated.
See also Table S2 and Figure S3.each set (Figures S3A and S3B; Tables 1 and S2) revealed
that the control set had 26 genes with no truncation, 3 genes
causing truncation, and no genes causing strong truncation.
Conversely, the tier 1 set contained only 15 genes with no
truncation, 11 genes causing truncations, and 3 genes causing
strong truncations, which was a significant enrichment in genes
required for canal extension compared with the control set2860 Cell Reports 24, 2857–2868, September 11, 2018(p = 0.0031). Tier 1 genes causing canal truncations (Figure 3A,
triangle- and diamond-outlined genes) represent a range of
cellular processes, such as rab-5 (early endosome targeting
GTPase), the Rho GEF ortholog ephx-1, the small GTPase
cdc-42, and sec-3/sec-15 (exocyst). We also identified a
number of genes that have no previously documented roles in
excretory canal morphology, including the chaperonin complex
subunit cct-2, the RNA lariat debranching enzyme dbr-1, polya-
denylate-binding protein pab-1, and Rad21/Rec8-like cohesion
protein scc-1. In addition, two uncharacterized genes, the RBM
(RNA binding motif-containing) ortholog H28G03.1 and nuclear
hormone receptor nhr-69, also caused canal truncations when
ablated.
Genes with CCM1/kri-1 Phenotypes
Because the methodology of both the RNAi screen and the
subsequent bioinformatic filtering do not bias against potential
CCM1/kri-1 interactors, we asked whether any of the tier 1 hits
would also cause kri-1 phenotypes. Loss of kri-1 causes resis-
tance to ionizing radiation (IR)-induced germline apoptosis in
the pachytene region (Ito et al., 2010) (Figure S3C, yellow
asterisks). Conversely, loss of ccm-3 causes oocyte growth
defects that leads to their death in the distal end of the germ-
line (Figure S3D, red asterisk). We quantified germ cell corpses
after ablating tier 1 genes by RNAi in wild-type worms exposed
to 60 Gy of IR, using kri-1 and the anti-apoptotic Bcl-2
homolog ced-9 as controls. Although ablation of some genes
(cct-2, cdc-25.1, cdc-42, erfa-1, T04G9.4, ubl-1, and unc-
112) caused germline defects that made it impossible to quan-
tify apoptotic corpses, five genes (Figure S3E; dbr-1, his-13,
icd-1, lin-23, and nhr-23) caused suppression of apoptosis
similar to kri-1 RNAi (n = 50, p < 0.05 from control RNAi,
p > 0.05 from kri-1 RNAi). If we define suppression as less
than or equal to the levels of physiological apoptosis, or two
corpses per gonad arm (Gumienny et al., 1999), ablation
of kri-1 by RNAi caused 50% suppression of apoptosis
(24 of 50 germline arms with two or fewer corpses). Only
his-13 RNAi caused a greater suppression of apoptosis
(29 of 50 germline arms) than kri-1.
mop-25.2 Is Required for Excretory Canal Integrity
Of the tier 1 hits (Figure S3A), knockdown of MO25 ortholog
mop-25.2 caused themost severe canal truncations (50 of 50 ca-
nals with canals <80%wild-type length) that were even more se-
vere than knockdown of ccm-3 or gck-1 (p < 0.05 in both cases)
(Figures 4A and 4B). Consistent with loss of ccm-3 (Lant et al.,
2015), we frequently observed distended lumen and distal canal
tip cysts in animals depleted ofmop-25.2 (Figure 4C, middle and
bottom). Interestingly, RNAi to either gck-1 or mop-25.2 signifi-
cantly exacerbated truncations in ccm-3 mutants (p = 1.089 3
109 and p = 2.49 3 105, respectively) (Figure 4D). We also
observed this with gck-1 mutant worms, in which depletion of
ccm-3 or mop-25.2 significantly enhanced canal truncations
(p = 3.303 1009, and p = 8.683 1008, respectively) (Figure 4D).
Previously, we found that loss of ccm-3 and STRIPAK genes
affected the stability of Golgi as well as subcellular localization
of CDC-42 and the endocytic recycling protein RAB-11 in the ca-
nal. Knockdown of mop-25.2 also diminished puncta for these
Table 1. Tier 1 Hits and Their Human Homologs
Gene Name WB Gene ID Truncation Rating Human Gene Homolog Human Gene ID
apl-1 WBGene00000149 no truncation APLP1 ENSG00000105290
cct-2 WBGene00000378 truncation CCT2 ENSG00000166226
cdc-25.1 WBGene00000386 truncation CDC25A ENSG00000164045
cdc-42 WBGene00000390 strong truncation CDC42 ENSG00000070831
dbr-1 WBGene00000937 no truncation DBR1 ENSG00000138231
ephx-1 WBGene00019487 truncation ARHGEF16 ENSG00000130762
erfa-1 WBGene00020269 no truncation ETF1 ENSG00000120705
glp-1 WBGene00001609 truncation NOTCH2 ENSG00000134250
H28G03.1 WBGene00019249 truncation HNRNPA1 ENSG00000135486
his-13 WBGene00001887 no truncation HIST2H3D ENSG00000183598
icd-1 WBGene00002045 truncation BTF3 ENSG00000145741
lin-23 WBGene00003009 no truncation FBXW11 ENSG00000072803
mop-25.2 WBGene00013140 strong truncation CAB39 ENSG00000135932
nhr-23 WBGene00003622 no truncation RORA ENSG00000069667
nhr-69 WBGene00003659 truncation HNF4A ENSG00000101076
pab-1 WBGene00003902 truncation PABPC4 ENSG00000090621
ppfr-2 WBGene00017064 no truncation PPP4R2 ENSG00000163605
rab-5 WBGene00004268 truncation RAB5B ENSG00000111540
rrc-1 WBGene00009800 no truncation ARHGAP30 ENSG00000186517
scc-1 WBGene00004737 truncation RAD21 ENSG00000164754
sdn-1 WBGene00004749 no truncation SDC1 ENSG00000115884
sec-15 WBGene00016188 truncation EXOC6 ENSG00000138190
sec-3 WBGene00018703 strong truncation EXOC1 ENSG00000090989
sek-6 WBGene00012162 no truncation MAP2K4 ENSG00000065559
skr-21 WBGene00004827 no truncation SKP1 ENSG00000113558
T02G5.7 WBGene00020166 no truncation ACAT1 ENSG00000075239
T04G9.4 WBGene00020215 no truncation AASDHPPT ENSG00000149313
ubl-1 WBGene00006725 no truncation RPS27A ENSG00000143947
unc-112 WBGene00006836 no truncation FERMT2 ENSG00000073712
Many C. elegans genes are the single homologs for multiple human genes or gene isoforms. Listed above are the human homologs on the basis of the
BLASTP matches per Wormbase.org. For an expanded list of possible human homologs, see Table S4.markers (Figure 4E; Table S3), indicating a similar role as CCM-3/
STRIPAK. Collectively, these results reveal a role for MOP-25.2
in canal extension by both CCM-3/GCK-1-dependent and
CCM-3/GCK-1-independent mechanisms.
Because there are three nematode MO25 paralogs in
C. elegans, in whichmop-25.1 andmop-25.3 are more distantly
related to mop-25.2 (Chien et al., 2013), we wondered if they
shared similar roles in canal development. Ablation of mop-
25.1 and mop-25.3 caused weak canal truncations (Figure S4)
and diminished puncta of CDC-42/recycling markers (Table
S3), which concurs with previous studies showing some overlap-
ping functions (Chien et al., 2013; Denning et al., 2012). Because
MO25 regulates AMPK signaling through the MO25/STRAD/
LKB1 complex (Boudeau et al., 2004; Hawley et al., 2003), we
wondered whether MOP-25.2 regulates canal extension through
the AMPK homolog. Therefore, we ablated both homologs of the
catalytic alpha subunit of AMPK (aak-1/aak-2), the upstream
LKB1 homolog (par-4), the ortholog of STRAD (strd-1), and the
STRD-1 associated kinase (sad-1). Only knockdown of par-4caused mild canal truncations (Figure S5), suggesting an alter-
nate function for MOP-25.2 in canal extension that is distinct
from its canonical binding partners.
mop-25.2 Is Required for Germline Rachis Stability
Loss of ccm-3 also causes sterility, whereby the germline lumen
(rachis) collapses and impairs oocyte growth (Pal et al., 2017)
(Figures 4F and 4G). Previously, mop-25.2 was shown to
be required for embryonic development, whereby the mop-
25.2(ok2073) deletion allele caused a maternal lethal effect
(Chien et al., 2013), so we wondered if mop-25.2 shared any
germline phenotypes with ccm-3. Using markers for both
germline nuclei (mCherry::HIS-58) and membranes (GFP::PH
[PLCdelta1]), knockdown ofmop-25.2 caused rachis membrane
collapse (Figure 4H, yellow asterisk) and small and rounded oo-
cytes (Figure 4H, blue asterisk) in approximately 60% of animals
(31 of 50). These germline defects were strikingly similar to those
caused by loss of ccm-3, providing further support for MOP-25.2
playing a key role in the biological functions of CCM-3/STRIPAK.Cell Reports 24, 2857–2868, September 11, 2018 2861
Figure 4. mop-25.2 Is Required for Excre-
tory Canal Extension and Germline Integrity
(A and B) (A) Knockdown of ccm-3, gck-1, and
mop-25.2 causes significant canal truncations (B)
(n = 50, *p < 0.05), withmop-25.2 significantly more
truncated than either (**p < 0.05). The red asterisk
denotes the distal worm measurement, and the
yellow asterisk indicates the end of the canal.
(C) Compared with wild-type (WT) canals, mop-
25.2 RNAi causes lumen defects and distal tip
cysts.
(D) Loss of either gck-1 or mop-25.2 in a ccm-3-
mutant background exacerbates canal trunca-
tions, and similarly, loss of ccm-3 ormop-25.2 in a
gck-1-mutant background causes more severe
truncations (all n = 50, *p < 0.05).
(E) Ablation of mop-25.2 reduces endocytic re-
cycling markers from the distal region of the canal
(see Table S3).
(F) Cartoon illustrating a healthy (wild-type)
C. elegans germline and a ccm-3 mutant with a
damaged germline.
(G) In ccm-3 mutants, the lumen bordered by the
rachis membrane collapses (white arrow), resulting
in underdeveloped oocytes (blue overlays).
(H) Using fluorescent membrane and nuclear
markers (GFP::PH [PLC1delta1], mCherry::his-58)
to visualize the germline, knockdown of mop-25.2
phenocopies ccm-3 mutants. Rachis collapse
(yellow asterisks) and small oocytes (blue aster-
isks) was observed in60% of worms treated with
mop-25.2 RNAi (n = 50).
Scale bars, 50 mm (A) and 10 mm (C, E, G, H). See
also Table S3 and Figures S4 and S5.mop-25.2 Is Required for CCM-3 Localization
Previously, we showed that ablation of gck-1 in the germline
caused CCM-3 to relocalize from the apical membrane to meiotic
nuclei (Pal et al., 2017). Because mammalian MO25 has been
shown to bind and stabilize GCKIII class kinases (Filippi et al.,
2011), and a MO25-GCKIII-CCM3 ternary complex may exist
(Yin et al., 2012), we asked ifMOP-25.2 affects CCM-3 localization
in a manner similar to GCK-1. CCM-3 localizes to apical mem-
branes in both the canal and germline (Lant et al., 2015; Pal
et al., 2017) (Figures 5A and 5B, top). Using GFP translational
reporters for CCM-3, we measured the fluorescence of
GFP::CCM-3 in the excretory canal (along the lumen) and the
pachytene region of the germline. Knockdown of ccm-3 caused
the expected dissipation of canal GFP::CCM-3 (Figure 5A), and
loss of gck-1 did not significantly diminish GFP signal compared
with controls (Figure 5A, fourth panel, and Figure 5C; p = 0.58),
but it did cause punctate patches (yellow asterisk) of CCM-3 along
canals. This punctate CCM-3 localization was observed in 12% of2862 Cell Reports 24, 2857–2868, September 11, 2018wild-type canals (n = 50), but ablation of
gck-1 significantly increased this to 46%
(p = 0.00014). Loss of mop-25.2, on
the other hand, significantly decreased
CCM-3 signal in the canal (p = 6.74 3
1010), although not to the same extent as
ccm-3 knockdown (Figure 5A, fifth panel,and Figure 5C). Canals of worms treated with mop-25.2 RNAi
did not have significantly increased levels of punctate CCM-3
compared with wild-type (p = 0.41). Similar effects were observed
in the germline. GFP::CCM-3 signal is on the luminal membrane of
the rachis (Figure 5B, yellow arrow/asterisk) above the pachytene
cells (Figure 5B, red asterisk).Where knockdownof ccm-3 ablated
the GFP signal (Figure 5B, second panels), as observed before,
loss of gck-1 caused CCM-3 relocalization into pachytene
nuclei (Figure 5B, third panels). However, loss ofmop-25.2 signif-
icantly diminished GFP::CCM-3 signal on the lumen (Figure 5B,
fourth panel, and Figure 5D; p = 1.02 3 1013) but did not cause
its relocalization to nuclei. Thus, although gck-1 and mop-25.2
both cause identical defectswhenablated, theydifferentiallyaffect
CCM-3 localization in both the excretory canal and germline.
mop-25.2 Is Required for GCK-1 Localization
Because mop-25.2 knockdown dramatically affected CCM-3
localization, we next asked if it had a similar effect on GCK-1.
Figure 5. mop-25.2 Is Required for Membrane Localization of CCM-3 and GCK-1
(A, B, E, and F, top panels) Both CCM-3 and GCK-1 localize to apical membranes of the excretory canal and germline.
(A) ccm-3 RNAi diminishes GFP::CCM-3 signal in excretory canals as expected (C; n = 50, *p < 0.05), whereas knockdown of gck-1 causes CCM-3 to relocalize
into discrete puncta along the apical membrane (yellow asterisk). Knockdown of mop-25.2 diminishes CCM-3 signal significantly (n = 50, *p < 0.05).
(B) GFP::CCM-3 localizes to rachis membrane in the germline (yellow arrow) around openings to the rachis (yellow asterisk) but not within the cell nuclei
themselves (red asterisks).
(C) ccm-3 RNAi diminishes GFP::CCM-3 signal in excretory canals as expected (n = 50, *p < 0.05), whereas knockdown of gck-1 causes CCM-3 to relocalize into
discrete puncta along the apical membrane (yellow asterisk). Knockdown of mop-25.2 diminishes CCM-3 signal significantly (n = 50, *p < 0.05).
(D) Depletion of gck-1 causes GFP::CCM-3 relocalization to germ cell nuclei, whereas mop-25.2 RNAi reduced its levels on the rachis membrane (n = 50,
*p < 0.05).
(E) GCK-1 in the canal is frequently punctate (yellow asterisks).
(F) In the germline, gck-1 RNAi completely ablates GFP::GCK-1 signal.
(G) Ablation of gck-1 or mop-25.2 reduced GFP::GCK-1 signal (n = 50, *p < 0.05), but knockdown of ccm-3 did not (see E), although it reduced punctate
localization by half (n = 50, p < 0.05).
(H) Depletion of ccm-3 or mop-25.2 significantly reduced GFP::GCK-1 membrane localization (n = 50, *p < 0.05). mop-25.2 RNAi also caused perinuclear
accumulation of GCK-1 (red asterisks) and patchy cytoplasmic localization of GFP::GCK-1 in oocytes (blue asterisks).
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Figure 6. Loss of MO25 Causes Stress Fiber
Formation in Endothelial Cells
(A–D) Pooled HUVECs transfected with control
siRNA (A), siCCM3 (B), and siMO25 (C) and incu-
bated with antibodies against VE-cadherin and
phalloidin (F-actin) were quantified for the forma-
tion of transverse actin fibers (SFs) (D). Loss of
both CCM3 and MO25 caused a significant in-
crease in stress fiber formation (n = 3 independent
experiments, *p < 0.05).GCK-1 co-localizes in a punctate manner with CCM-3 along the
apical membrane of the canal (Figure 5E, yellow asterisks) and
the rachis membrane of the germline (Figure 5F, yellow arrow/
asterisk). Ablation of gck-1, as expected, caused signal to disap-
pear in both tissues (Figures 5E and 5F, second panels, and Fig-
ures 5G and 5H). In the canals, ablation of ccm-3 did not change
either GCK-1::mCherry localization or its fluorescence intensity
(p = 0.18) (Figure 5E, third panel, and Figure 5G), but it did
reduce the punctate distribution of GCK-1 to 30% (16 of 50,
p = 0.0086). Similarly, in the germline, loss of ccm-3 did not
cause relocalization of GCK-1 but significantly diminished its
signal (p = 4.35 3 1016) along the rachis membrane (Figure 5F,
third panel, and Figure 5H). As with GFP::CCM-3, knockdown
of mop-25.2 caused a significant reduction of GCK-1 signal
in the apical membranes of both the canal and germline2864 Cell Reports 24, 2857–2868, September 11, 2018(p = 5.11 3 1009 and p = 3.24 3 1014,
respectively) (Figures 5E and 5F,
fourth panels, and Figures 5G and 5H).
Interestingly, ablation of mop-25.2 also
reduced the punctate localization of
GCK-1::mCherry (p = 0.0022) in the
canal and increased its perinuclear and
patchy cytoplasmic localization in oo-
cytes (p = 0.00028) (Figure 5F, fourth
panel insets, red and blue asterisks,
respectively). Thus, MOP-25.2 regulates
the integrity of the excretory canal and
germline, most likely by controlling the
localization of CCM-3 and GCK-1.
Knockdown of CCM3 and MO25
Causes Stress Fibers in Endothelial
Cells
In order to assess if the role ofmop-25.2 is
conserved, we ablated both CCM3 and
MO25 in human umbilical vein endothelial
cells (HUVECs) and assessed stress
fiber (SF) formation. Loss of CCM pro-
teins cause actin stress fibers through
increased RhoA/ROCK activity (Richard-
son et al., 2013; Stockton et al.,
2010). Staining for both VE-cadherin and
F-actin, we observe the change in dy-
namics between the two (Abu Taha and
Schnittler, 2014). With control scrambled
(SCR) small interfering RNA (siRNA),VE-cadherin and F-actin largely co-localize at cell junctions
(Figures 6A–6C). However, siRNA to both CCM3 and MO25
lock the actin into transversal arcs that cross the nucleus and
stretch across the cell (Tojkander et al., 2012). Prevalence of
stress fibers in cell populations (Figure 6D) showed significant
increases with siRNA to CCM3 and MO25 (p = 0.0083 and
p = 0.018, respectively, n > 300), indicating that loss of MO25
phenocopies loss of CCM3 in endothelial cells.
DISCUSSION
Here, we took advantage of the genetic tools of C. elegans to
interrogate the CCM gene network, focusing on the less studied
CCM3 branch. Our RNAi screen identified 562 genes that cause
negative genetic interactions in kri-1/CCM1 mutants, similar to
ablation of ccm-3. Although we focused on the 237 genes with
annotated interactions, greater data integration of the ‘‘orphan
genes’’ in the future should provide more insights into their
gene-gene interactions and biological functions. Many of the
genes with well-documented interactions clustered into a limited
but functionally diverse number of biological processes,
including protein translation, cytoskeletal dynamics, and vesicle
trafficking (Figure 2; Table S1). This is consistent with our previ-
ous work showing a role for CCM3 in these processes to control
biological tube integrity (Lant et al., 2015; Pal et al., 2017). Our
screen uncovered several expected hits, including genes encod-
ing small GTPases, Notch, MAPK, and KLF (Table S1), confirm-
ing the robustness of thismethod (Borikova et al., 2010;Ma et al.,
2007; You et al., 2013; Zhou et al., 2015). The identification of cell
cycle, histone, and ion channel genes (Figure 2; Table S1), ex-
pands the number of biological processes affected by CCM
signaling, which will be interesting to investigate in the future.
We were particularly interested in characterizing the functions
of genes that are conserved in humans. Using the bioinformatics
platforms GeneMANIA and STRING (von Mering et al., 2005;
Mostafavi et al., 2008) to generate a human CCM-ome allowed
us to interrogate a limited set of genes predicted to have
conserved functions in CCM biology. Remarkably, of the
29 tier 1 genes, 14 caused significant excretory canal truncations
when ablated. Genes that regulate canal integrity are uncommon
(Buechner et al., 1999; Sundaram and Buechner, 2016), and of
these 14 genes, 3 were previously known to affect the excretory
canal: glp-1 (Abdus-Saboor et al., 2011), rab-5 (Mattingly and
Buechner, 2011), and cdc-42 (Lant et al., 2015). The remaining 11
genes exhibit previously undocumented excretory cell pheno-
types. Because the tier 1 genes might also function in the
KRI-1/CCM1 pathway, we evaluated their role in germline
apoptosis and found that 5 genes (Figure S3E) conferred resis-
tance to radiation-induced germline apoptosis when ablated,
similar to kri-1. Although this is not as striking as the frequency
of genes that affect the excretory canal, it is possible that we
have uncovered some genes in which the CCM-3 and KRI-1
pathways converge. Only ablation of his-13, exceeded ‘‘kri-1-
level’’ apoptosis suppression, and while his-13 has not been
reported to affect IR-induced germline apoptosis, histones
affect the expression of many genes, so it will be interesting to
determine if his-13 has a direct role in CCM signaling.
Tier 1 genes causing ccm-3-like canal truncations included a
number of small GTPases and small GTPase regulators, which
is not surprising given that RhoA is hyper-activated in the
absence of CCM proteins (Richardson et al., 2013; Stockton
et al., 2010). We previously reported that CCM-3 regulates
another small GTPase, CDC-42 (Lant et al., 2015), which was
also identified as a tier 1 hit in this study (Figure S3; Table 1). In
addition, we identify a number of GTPase related genes (Fig-
ure 2), including the Rho GEF ephx-1, which has been reported
to regulate CDC-42 activity in both nematodes and human cells
(Oliver et al., 2011; Walck-Shannon et al., 2016). Therefore, we
predict that a more extensive network of small GTPases are
involved in CCM signaling.
Consistent with our previous work showing that CCM-3/
STRIPAK regulates endocytic recycling (Lant et al., 2015; Pal
et al., 2017), several tier 1 genes encode vesicle-trafficking pro-teins, including the early endosomal GTPase rab-5 and exocyst
complex genes sec-3 and sec-15. This is significant because we
previously discovered a link between CCM-3 and the exocyst
complex gene exoc-8 (Lant et al., 2015), which was also identi-
fied in the RNAi screen. Work by Armenti et al. (2014) identified
important roles for the exocyst gene sec-5 and the exocyst
complex regulator ral-1 in excretory canal development, with
localization of exocyst proteins to apical membrane mediated
by polarity proteins. Combined, our work showing that CCM-3
is required for proper localization of the polarity proteins PAR-2
and PAR-6 (Pal et al., 2017) suggests that CCM-3 may coordi-
nate polarity establishment and endocytic trafficking during
biological tube development.
Many of the tier 1 genes had not been previously implicated in
functions related to CCM-3/CCM3 signaling, and of these, the
most intriguing gene to us was the MO25/CAB39 homolog
mop-25.2. Not only did its ablation cause the strongest canal
truncations, but it also had similar germline defects as observed
in ccm-3 and gck-1mutants (small oocytes and rachis collapse)
(Figure 4). Although mop-25.2 is required for localization of
CCM-3 to apical membranes, its co-ablation with ccm-3 or
gck-1 caused additive effects on canal truncations (Figure 4D).
We propose that MOP-25.2 functions to integrate CCM-3/
GCK-1, and likely other factors, to promote canal extension
and germline integrity. Although mammalian MO25 is best
known to regulate AMPK signaling, its role in C. elegans tubulo-
genesis is independent of its canonical binding partners LKB1/
STRAD and AMPK (Figure S5). Canal defects caused by knock-
down of par-4 and mop-25.2, but not strd-1 and the AMPK
genes, are interesting in light of observations showing that
par-4 and strd-1 function independently of their canonical
pathway (Narbonne and Roy, 2009; Narbonne et al., 2010).
The impact of losingmop-25.2 onCCM-3 localization at the ca-
nal lumen and germline rachis is distinct from gck-1 loss, which
caused CCM-3 to localize into discrete puncta in the canal (Fig-
ure 5A) and nuclei of the meiotic germline (Figure 5B) (Pal et al.,
2017). Interferingwith binding toGCK-1 causesCCM-3 to relocal-
ize to the nucleus,whereas lossof binding toCASH-1 (striatin) dis-
rupts apical membrane localization but not nuclear relocalization
(Pal et al., 2017). Loss ofmop-25.2 also causedGCK-1 to become
dissipated from apical membranes in both tissues, showing that it
has a CASH-1-like effect on localization of the CCM-3/GCK-1
complex to apical membranes. It will be interesting to determine
whether MOP-25.2 interacts with the CASH-1 branch of the
CCM-3 network to direct CCM-3/GCK-1 to luminal membranes.
However, becausewedidnot identifyMOP-25.2asabindingpart-
ner of theCCM-3/STRIPAKcomplex (Pal et al., 2017), it is possible
that itmight affect the synthesisor stability ofCCM-3,whichwould
subsequently alter GCK-1 localization. Although this collectively
supports the co-dependency of CCM3 and GCKs in localization
to apical membranes (Fidalgo et al., 2010, 2012; Ma et al., 2007;
Zhang et al., 2013b), it also reveals a role for MOP-25.2 in the
CCM-3/STRIPAK network. Clearly, there is much to learn about
the non-canonical roles of MO25/MOP-25.2.
Because it shares a similar function with CCM3 in stress fiber
formation in cells, MO25 may be an important determinant of
CCM disease. Prevention of stress fiber formation by inhibiting
RhoA/ROCK (Richardson et al., 2013; Stockton et al., 2010)Cell Reports 24, 2857–2868, September 11, 2018 2865
downstream of the hetero-trimeric complex is an attractive
therapeutic strategy for managing this disease (McDonald
et al., 2012; Shenkar et al., 2017). Our observations suggest
that MOP-25.2/MO25 affects the stability of CCM-3/CCM3-con-
taining complexes, andwe suspect that the severity of disease in
CCM3 patients may be due to its loss frommultiple protein com-
plexes. Exploiting the powerful genetics of C. elegans has pro-
vided insights into how CCM3 functions in vivo and uncovered
nodes in this network that might offer therapeutic strategies for
managing this disease in humans.
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Anti-VE-Cadherin Antibody (CD144), clone BV9 Millipore Sigma/Merck
Millipore
Cat # sc-52751 (RRID: AB_628919)
TRITC-conjugated phalloidin Sigma Aldrich FAK100 part 90228
Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary
Antibody, Alexa Fluor Plus 488
Invitrogen Cat # A32723 (RRIID: AB_2633275)
Bacterial and Virus Strains
Caenorhabditis elegans RNAi feeding library Source Bioscience https://www.sourcebioscience.com/
products/life-science-research/clones/
rnai-resources/c-elegans-rnai-collection-
ahringer/
OP50 (E. coli) Caenorhabditis Genetics
Center
WormBase ID: OP50
Chemicals, Peptides, and Recombinant Proteins
Ampicillin Sigma-Aldrich A1593; CAS Number 69-53-4
Tetracycline hydrochloride Sigma-Aldrich T7660; CAS Number 64-75-5
Isopropyl-b-D-thiogalactopyranoside (IPTG) Sigma-Aldrich I1284; CAS Number 367-93-1
Tetramisole Sigma-Aldrich T1512; CAS Number 5086-74-8
Penicillin/Streptomyocin Sigma-Aldrich P4333
Fibronectin Human Plasma Sigma-Aldrich F0895
Rat Tail Collagen I Corning Product # 354236
Vasculife VEGF Medium Lifeline Cell Technology LL-0005
EBM-2 Basal Medium Lonza CC-3156
Lipofectamine RNAi max Life Technologies ref. 13778-150
Trypsin inhibitor Sigma-Aldrich T6522
Mowiol Sigma-Aldrich 324590
Experimental Models: Cell Lines
HUVEC-Umbil Vein, Pooled Cells Lonza CC-2519, C2519A
Experimental Models: Organisms/Strains
C. elegans: Strain N2 Caenorhabditis Genetics
Center
WormBase ID: N2
C. elegans: Strain BK204: qpIs96[Pexc-9::mCherry::cdc-42] The Buechner Laboratory WormBase ID: BK204
C. elegans: Strain BK205: qpIs97[Pexc-9::mCherry::rab-11]V The Buechner Laboratory WormBase ID: BK205
C. elegans: Strain BK220: qpIs103[Pexc-9::mCherry::GRIP] The Buechner Laboratory WormBase ID: BK220
C. elegans: Strain BK262: qpIs104[Pexc-9::mCherry::GBDwsp-1] The Buechner Laboratory WormBase ID: BK262
C. elegans: Strain OD95: unc-119(ed3) III; ltIs37 [pAA64;
pie-1::mCherry::HIS-58 + unc-119(+)] IV; ltIs38 [pAA1;
pie-1::GFP::PH(PLC1delta1) + unc-119(+)]
Caenorhabditis Genetics
Center
WormBase ID: OD95
C. elegans: Strain WD187: kri-1(ok1251)I; bgls312{Pvha-8::GFP} The Derry Lab N/A
C. elegans: Strain WD188: ccm-3(tm2806)/mIn1[mIs14
dpy-10(e128) let(gk838)]II; bgls312{Pvha-8::GFP}
The Derry Lab N/A
C. elegans: Strain WD355: onIs3 {Pccm-3::GFP::CCM-3;
unc-119(+)}II; unc-119(ed3) III
The Derry Lab N/A
C. elegans: Strain WD419: N2; onEx62[Pexc-9::ccm-3::GFP;
Pmyo-2::mCherry; Pmyo-3::mCherry; Prab-3::mCherry]
The Derry Lab N/A
C. elegans: Strain WD423: N2; onEx69[Pexc-9::ccm-3::GFP;
Pexc-9::gck-1::mCherry; rol-6(su1006)]
The Derry Lab N/A
(Continued on next page)
Cell Reports 24, 2857–2868.e1–e4, September 11, 2018 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
C. elegans: StrainWD472: gck-1(onIs11
[gck-1::GFP::3xFlag+loxP SEC loxP]) III
The Derry Lab N/A
Oligonucleotides
siRNA (siCT) Dharmacon ref D-001810-01
siRNA (siCCM3) Dharmacon ref L-004436-01
siRNA (siMO25) Dharmacon ref L-015407-01
Software and Algorithms
BioMart Ensembl http://useast.ensembl.org/biomart/martview/
2e75a78fc2af8b2fa42aeeb328b837e9
GeneMania Jason Montojo/ GeneMania
Team (University of Toronto)
https://genemania.org/ and http://apps.
cytoscape.org/apps/genemania
ImageJ Wayne Rasband/ NIH http://imagej.nih.gov/ij
OpenLAB Agilent https://www.agilent.com/en-us/products/
software-informatics/openlab-software-suite
STRING Swiss Institute of
Bioinformatics, CPR-NNF
Center for Protein Research,
and European Molecular
Biology Laboratory
https://string-db.org/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Brent
Derry (brent.derry@sickkids.ca).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Caenorhabditis elegans strains and maintenance
Worms were cultivated on lawns of E. coli (strain OP50) grown on NGM (nematode growth medium) plates at 20C (unless otherwise
stated) (Brenner, 1974). Wild-type (WT) refers to the C. elegans variety Bristol, strain N2. Compound mutant and transgenic strains
were constructed according to standard C. elegans protocols (Fay, 2008). See KRT for strain list. Excretory canal marker strains
designated ‘BK’ were a kind gift from Dr. Matthew Buechner.
Endothelial cell growth conditions
Pooled HUVECs were grown on collagen I coated plates in complete EBM media, supplemented with 100U/ml penicillin and
100 mg/ml streptomycin, at 37C in a 5% CO2-humidified chamber according to the manufacturer’s instructions. HUVEC
(1.5 3 106 cells) were transfected twice at 24 h intervals with 20 nM siRNA and 45 mL lipofectamine RNAi max according to the
manufacturer’s instructions.
METHOD DETAILS
RNA interference
RNAi was performed by feeding bacteria expressing double-stranded RNA (RNAi) to worms at the L1 stage, according to Kamath
et al. (Kamath et al., 2001). Bacterial cultures expressing double-stranded RNA targeting the gene of interest were drawn from
the Source BioScience RNAi library, and grown on nematode growth media (NGM) plates supplemented with antibiotics
(50 mg/ml ampicillin and 12.5 mg/ml tetracycline) and 0.1 mM isopropyl-b-D-thiogalactopyranoside to induce dsRNA production.
Bacteria expressing an empty RNAi vector (L4440; within competent HT115 cells) were used as controls. For excretory canals
analysis, to decrease variance between worms, RNAi was concentrated 5X, and worms were grown on RNAi bacteria for two
generations. In the cases where worms did not survive two full generations of RNAi, L4s were placed on the bacteria, and subsequent
F1 progeny were analyzed.
Whole Genome RNAi Screen
We previously observed that ablation of ccm-3 and kri-1 causes synthetic lethality (Lant et al., 2015). Hence, we reasoned that other
genes that cause synthetic conditions (‘sickness’) when knocked down in kri-1(ok1251)mutants might reveal additional componentse2 Cell Reports 24, 2857–2868.e1–e4, September 11, 2018
of the ccm-3 pathway. kri-1(ok1251)mutants were fed bacteria expressing dsRNA to genes from the Source Bioscience RNAi library
in liquid culture format (96 well plates). A 96 pin-replicator was plunged into the wells of a thawed RNAi library plate (4 pins/plates per
384 well library plate), then immersed in 150ml of LB+AMP+TET, aliquoted into each well of a conical tip 96 well plate. The plates were
covered in parafilm and a wet paper towel, placed in a sealed plastic bag to prevent evaporation, then incubated on a shaker over-
night at 37C. The following day bacterial cultures were induced with 6ml IPTG (0.1M) per well, and incubated for onemore hour. Bac-
teria was pelleted by centrifugation (3,500rpm) for 5 min, the supernatant removed, and pellets re-suspended in150ml liquid NGMper
well. 50ml of this induced bacterial RNAi culture was transferred to a flat-bottom 96 well plate and 10 L1 stage kri-1(ok1251)mutant
worms were added. The plates were sealed (as above) and placed on an orbital shaker at room temperature and grown 4-5 days.
Sickness (embryonic lethality, larval lethality, sterility, and slow growth) of F1 progeny from kri-1 mutants was assessed and cata-
loged. Concurrently, N2 (WT) controls were grown in the same RNAi conditions (in separate wells). Negative genetic interactions
based on synthetic lethal and sick phenotypes were categorized as those observed in kri-1 but not N2 controls.
C. elegans microscopy
Nematodes were slide mounted in a 5ml aliquot of tetramisole anesthetic (20-100mM; higher concentration for roller strains), on a flat
pad of 4% agar. Nematodes were imaged at 63X or 100X magnification using a Leica DMRA2 compound microscope equipped dif-
ferential interference contrast (DIC) optics and epifluorescence. Images were captured with a Hamamatsu C472-95 digital camera
using Openlab software (PerkinElmer Inc.).
Bioinformatics
A master list of 35 genes (from mammalian CCM literature was converted into gene and protein IDs via BioMart (Ensembl), and then
used to generate ‘CCM-omes’ via GeneMANIA and STRING, respectively. For the gene lists a total of 500 were obtained by selecting
for biological relevance using GO term sorting for GO Biological Process, GO Molecular Function, and GO Cellular Component in
GeneMANIA. The amalgamated GeneMANIA list (i.e., removing multiple entries for the same genes) amounted to 769 genes. For
the protein interaction list STRING was used to generate a list of 500 proteins, using its automatic weighting system. These lists
were converted to worm orthologs via BioMart, resulting in 535 independent genes from the GeneMania list and 231 genes from
the STRING list. Further amalgamation of these two lists produced a final worm ‘‘CCM-ome’’ of 653 genes. The overlapping genes
between the ‘Sick’ list from the RNAi screen (562 genes) and the CCM-ome list (653 genes) were termed ‘‘Tier 1’’ hits, which
amounted to 29 genes (‘Experimental Set’) that were examined for canal effects against 29 randomly selected (‘Control Set’) genes.
The ID of Control set genes were generated by assigning a number to each gene in the Source Bioscience RNAi library, and then
generating a random list of 29 numbers using the RAND function in Microsoft Excel.
Cell spreading and immunofluorescence
Transfected cells were trypsinized, treated with 1 mg/ml trypsin inhibitor, and incubated in serum-free EBM-2/1% BSA for 30 min at
37C. Sparse HUVECs (104) were spread for 4h on 24-well plates slides coated with 2 mg/ml of Fibronectin (FN), in vasculife VEGF
media containing 5% FN-depleted serum and then fixed with 4% PFA. Confluent HUVECs (2 3 105 cells) were seeded in 24-well
plates on slides coated with 20 mg/ml FN and incubated for 72h in complete vasculife media. Cells were fixed with 4% PFA,
permeabilized with 0.2% Triton X-100, and incubated with VE-cadherin BV9 antibody at 1/200 dilution. After rinsing, coverslips
were incubated with an Alexa Fluor 488–conjugated secondary antibody and phalloidin-TRITC. The cells were mounted in
Mowiol/DAPI solution and imaged on epifluorescent Axiomager microscope (Zeiss) with AxioCamMRc camera.
QUANTIFICATION AND STATISTICAL ANALYSIS
Significance of the Tier 1 set (29 genes) of hits generated from overlapping genes in the informatics set (653 genes) and the genome
screen set (562 genes) was validated through a hypergeometric analysis and was found to be significant (p = 0.012). Additionally,
randomizing sets of numbers (n = 10), the average overlapping values for comparisons of 653 and 562 numbers resulted in
18.2 ± 4.6 (mean ± standard deviation), wherein our value of 29 is outside of two standard deviations.
Excretory canal lengths were measured from excretory cell to the canal tip. These values were normalized by a ‘total’ length
measurement of the worm (excretory cell to anus), with the ‘relative’ canal length expressed as a percentage according to Lant
et al., 2015. Individual canal measurements were plotted in GraphPad Prism, with mean values marked by a red bar.
Germline apoptotic corpse counts were performed 24 hr post IR, following a 60 gy dosage at the young adult stage. Germlines
were observed and counted directly at 630X magnification using a Leica DMRA2 compound microscope. Individual germline arm
corpse counts were plotted in GraphPad Prism, with mean values marked by a red bar. Values were accumulated from three or
more experimental datasets. P values, relative to ‘control RNAi’ were determined using a two-tailed Student’s t test, assuming equal
variance. Significance levels (P value) and sample size (N) are marked in each corresponding figure legend.
Comparison of Control and Experimental sets of data, cumulatively, using a two tailed Student’s t test, assuming equal variance,
showed the two sets to be significantly different (p = 6.92762E-36). Comparison of Control and Experimental sets, as collections of
genes with a rating of no truncation, truncation, or strong truncation was conducted using the CHI square test and showed the two
groups to have significantly different distributions in these categories (p = 0.0031).Cell Reports 24, 2857–2868.e1–e4, September 11, 2018 e3
Puncta counts and fluorescent signal measurements were obtained using ImageJ software. Puncta counts were measured (Lant
et al., 2015) using an RGB profile plot on a stretch of canal (100mm in length) at or near the posterior distal tip. Each representative
image shows a single plane, of one canal, with the maximal amount of puncta present. Relative intensity of GFP/RFP signals were
assessed bymeasuring the requisite RGB channel signal, and normalizing with RGB signal from surrounding tissue (canals), or within
the pachytene cells (germline rachis) in which a neutral ‘non-signal’ holds a value of 1. In each case, values have been compared from
the given RNAi type to a control (empty vector) RNAi.
For quantification of the number of cells displaying transversal actin fibers (stress fiber) above their nucleus,more than 100 cells per
phenotype in 3 independent experiments were counted, and the relative frequency of stress fiber presence was normalized for con-
trol siRNA numbers.e4 Cell Reports 24, 2857–2868.e1–e4, September 11, 2018
